Our PM commercialization model

Diaceutics relay

The commercialization model built for precision medicines
pre-launch
launch
post-launch

Move from diagnosis to therapy, as one system

When testing, intelligence and engagement work as one, more eligible patients are identified for treatment—and diagnostic results are more consistently translated into action.

Diaceutics Relay gives you one connected model for the moments that decide uptake. It brings the power of the Diaceutics portfolio together for precision medicines—turning diagnostic intelligence into coordinated action across labs, HCPs and field teams while decisions can still change.

Use it to solve one urgent challenge, or scale it across pre-launch, launch and in-market growth as a commercialization partnership built around your goals.

The result: less fragmentation, sharper prioritization and a clearer path from diagnosis to therapy.

Woman-in-hospital-bed
Woman-in-hospital-bed
125 +
precision medicine brands supported
87
biomarker commercializations supported
299 M
de-identified tokenized patients across integrated datasets
200
global experts across our team
*Source: Data insights sourced from Diaceutics’ client projects.
“The work we’ve done with Diaceutics has accelerated our commercialization and improved the penetration of our new brand within the market.”
Director Analytics & Strategic Operations
Biotech Company

See, prioritize, activate

Explore how Reveal, Signal and Diaceutics solutions work together across the journey—from understanding where patients are missed, to preparing for launch, activating at diagnosis and growing adoption.

Diaceutics diagram_v13_Final_with_BG

One model. The right moves for your launch.

Pre-launch, launch or in-market, Relay flexes around what your therapy needs next. Start with one priority, or scale into a full commercialization partnership that keeps strategy, intelligence and engagement moving together.

Feature: Diaceutics Relay in action
Case Study
Relay
Oncology

Building a precision medicine launch blueprint

A seven-year embedded partnership helped a global top 20 pharma company prepare, launch and sustain adoption for its first precision oncology therapy, from early planning to lifecycle management.
chevron-outline
92%
audience reached through Diaceutics campaigns

Why Diaceutics relay?

Deploy the only model built for precision medicine
Bring testing, intelligence and engagement together for precision medicine launches—so your teams can act on the diagnostic moments that move patients toward treatment.
Act while decisions are forming
Use real-time diagnostic intelligence and engagement to support HCPs and labs with awareness, education and peer exchange while decisions can still change.
Move insight into action
Reveal, Signal and Engagement Solutions work as one system, so strategy and execution move together and teams know where, when and how to act.
Reach every stakeholder that matters
Connect across the Diaceutics Lab Network and HCP relationships to engage the stakeholders involved in testing, interpretation and treatment decisions.
Targeted, efficient and scalable by design
Replace broad, resource-heavy commercialization with targeted, data-led engagement—focusing effort where it matters. Start with a targeted intervention or deploy Relay as a coordinated partnership.
Share accountability for adoption
Flexible delivery models, including milestone-based and performance-linked structures, aligning what you invest with the adoption Relay drives.
“I view Diaceutics as a commercialization partner offering a full suite of solutions and thought partnership that has helped us get where we are today - and will help us get where we want to be tomorrow.”
Director Analytics & Strategic Operations
Biotech company

Move from challenge to Coordinated action

Relay is shaped around the challenge in front of you. Tell us where commercialization is stalling—from targeting and testing to engagement and adoption—and we’ll help you build the right connected model to move from diagnosis to therapy.

 

  • Connect diagnostic intelligence, engagement and expert support in one model.

  • Focus action around your therapy, market and commercial priority.

  • Move from identifying eligible patients to supporting therapy adoption.

Explore our integrated solutions

Identify the treating HCP earlier
Detect therapy-relevant diagnostic activity and identify treating HCPs while treatment decisions are still forming.
EXPLORE SIGNAL
Engage HCPs at the right moment
Reach treating HCPs with timely, clinically relevant engagement shaped by real diagnostic activity.
EXPLORE PHYSICIAN ENGAGE
Strengthen diagnostic readiness
Focus lab engagement where testing gaps exist and where priority labs can influence adoption.
EXPLORE LAB ENGAGE
Bring peer expertise into action
Connect HCPs with trusted experts to support diagnostic confidence and treatment consideration.
EXPLORE EXPERT EXCHANGE

FAQs

What is Diaceutics Relay?
Diaceutics Relay is a commercialization partnership model that brings diagnostic intelligence and engagement together for precision medicine launch and adoption.
How does Relay work?
Relay brings Reveal, Signal, Insight Services and Engagement Solutions together as one sequence of action—showing where the pathway is moving, identifying therapy-relevant moments and activating the right mix of HCP, lab and expert engagement to help more eligible patients move from diagnosis to therapy.
What problem does Relay solve?
Relay helps reduce fragmentation by connecting testing, intelligence, targeting, engagement and adoption activity in one coordinated commercialization model.
When should teams use Relay?
Teams can use Relay to solve one urgent adoption challenge or scale it into a full commercialization partnership across pre-launch, launch and in-market growth.
What solutions can be included in Relay?
Relay can bring together Reveal, Signal, Engagement Solutions and expert support, shaped around the customer’s therapy, pathway, launch stage and adoption goals.
How is Relay different from using separate vendors?
Relay brings intelligence, engagement and expert support into one coordinated model, reducing the risk that testing, targeting, engagement and adoption stall in separate workstreams.
Does Relay support shared accountability?
Yes. Relay can be structured around milestone-based and performance-linked delivery models, helping align investment and execution with real-world adoption and brand performance.
FAQs template-img (1)